WAVE Life Sciences Ltd.
WVE
$13.02
-$0.33-2.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 602.07M | 196.22M | 208.48M | 243.08M | 302.08M |
| Total Receivables | 1.28M | 10.00M | 1.62M | -- | 1.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.40M | 6.65M | 6.70M | 8.06M | 9.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.08M | 2.62M | 6.76M | 6.84M | 7.35M |
| Total Current Assets | 614.81M | 215.49M | 223.56M | 257.98M | 320.39M |
|
|
|||||
| Total Current Assets | 614.81M | 215.49M | 223.56M | 257.98M | 320.39M |
| Net Property, Plant & Equipment | 19.86M | 22.07M | 24.29M | 26.15M | 28.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.82M | 3.82M | 4.51M | 4.22M | 3.82M |
| Total Assets | 638.50M | 241.38M | 252.36M | 288.34M | 352.21M |
|
|
|||||
| Total Accounts Payable | 15.70M | 14.49M | 14.66M | 14.36M | 16.26M |
| Total Accrued Expenses | 26.56M | 16.49M | 13.03M | 7.81M | 21.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.36M | 8.39M | 8.14M | 7.88M | 7.64M |
| Total Finance Division Other Current Liabilities | 44.44M | 46.53M | 51.58M | 57.31M | 65.97M |
| Total Other Current Liabilities | 44.44M | 46.53M | 51.58M | 57.31M | 65.97M |
| Total Current Liabilities | 95.07M | 85.90M | 87.41M | 87.37M | 110.95M |
|
|
|||||
| Total Current Liabilities | 95.07M | 85.90M | 87.41M | 87.37M | 110.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.41M | 11.38M | 13.58M | 15.72M | 17.77M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.80M | 11.68M | 4.23M | 5.58M | 6.10M |
| Total Liabilities | 112.27M | 108.96M | 105.22M | 108.67M | 134.82M |
|
|
|||||
| Common Stock & APIC | 1.84B | 1.40B | 1.36B | 1.34B | 1.33B |
| Retained Earnings | -1.33B | -1.27B | -1.22B | -1.17B | -1.12B |
| Treasury Stock & Other | -250.00K | -190.00K | -161.00K | -204.00K | -262.00K |
| Total Common Equity | 518.36M | 124.55M | 139.27M | 171.80M | 209.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
|
|
|||||
| Total Common Equity | 518.36M | 124.55M | 139.27M | 171.80M | 209.52M |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 526.23M | 132.42M | 147.14M | 179.68M | 217.39M |
|
|
|||||